...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >A survey of physicians' attitudes toward uterotonic administration in parturients undergoing cesarean section
【24h】

A survey of physicians' attitudes toward uterotonic administration in parturients undergoing cesarean section

机译：医生对剖宫产术中子女辐射管理的态度态度调查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: Oxytocin is globally accepted as first-line treatment for prevention of post-partum hemorrhage. However, there is wide variability in its use in clinical practice. In this study, we aimed to evaluate obstetricians and anesthesiologists attitudes towards uterotonic practices in Israel. Study design: The current survey was designed to study the preferences of obstetricians and anesthesiologists in seven University hospitals regarding the type, dose, and mode of administration of uterotonic drugs, as well as their knowledge regarding the side effects of these drugs. Results: A total of 429 anesthesiologists and obstetricians were approached for participation. Three hundred and ninety-one physicians responded: 48% obstetricians and 52% anesthesiologists. Variations in oxytocin practices were significantly different between obstetricians and anesthesiologists in primary CS (p<.01). Nonetheless, both cohorts reported using an aggressive approach, administering an IV bolus of 5 or 10 units. In repeat CS no significant difference was demonstrated (p - .065). Additionally, we found increased treatment with Methergine as a second-line uterotonic management.
机译：目的：催产素被全球接受作为预防枸杞后出血的一线治疗。然而，在临床实践中使用广泛的可变性。在这项研究中，我们旨在评估产科医生和麻醉学家对以色列的子宫态度的态度。研究设计：目前的调查旨在研究七所大学医院的产科医生和麻醉师的偏好，了解子宫药物的类型，剂量和给药方式，以及他们对这些药物副作用的知识。结果：参与共有429名麻醉学家和产科医生。三百九十一医生作出反应：48％的产科医生和52％的麻醉师。催产素实践的变化在初级Cs的产科医生和麻醉学家之间具有显着差异（p <.01）。尽管如此，两个群组都报告使用侵略性的方法，施用5或10个单位的IV推注。在重复CS中，证明了没有显着差异（p-.065）。此外，我们发现使用Methergine作为二线子宫管理的治疗增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号